Genito-urinary Cancer

Multi-targeted 'chemo-switch' regimen could offer new option in RCC

19/02/2010 | A multi-targeted 'chemo-switch' drug regimen shows promising anti-tumour activity with manageable side effects in patients with metastatic renal-cell carcinoma, Spanish researchers report.


High volume surgeons save money

12/02/2010 | Patients who undergo radical prostatectomy in hospitals with higher rates of the procedure have better outcomes, fewer postoperative complications and lower hospital costs, but this should not fuel arguments for centralisation of the operation, surgeons say.


Medroxyprogesterone best for hot flushes in prostate cancer

10/12/2009 | Medroxyprogesterone should become the standard treatment for preventing hot flushes in men receiving hormone therapy for prostate cancer, researchers suggest.


Prostate treatment impairs quality of life

04/12/2009 | An Australian study has confirmed that men who receive treatment for early prostate cancer have a much reduced quality of life because of persistent impotence and incontinence.


Use contraception after HPV vaccine

26/11/2009 | Sexually active women seeking HPV vaccination should be advised to use contraception until one month after the third dose, reproductive health specialists say.


New ACOG cervical cancer screening guidelines

26/11/2009 | The American Congress of Obstetricians and Gynaecologists will release updated guidelines on cervical cancer screening next month.


Extracapsular spread most valuable prognostic factor

16/10/2009 | Extracapsular spread appears to be the most valuable lymph-node associated prognostic factor for survival in vulva cancer, Australian and Dutch researchers report.


HPV Vaccination not cost effective for boys

16/10/2009 | Vaccinating boys against human papillomavirus is not likely to be cost effective on a population level, a BMJ analysis concludes.


Experts say no to ovarian cancer screening

30/09/2009 | There is no evidence to support the use of any test to screen asymptomatic women for ovarian cancer, according to a new position statement released by a consortium of Australian expert groups. 1 comment


PSA screening fails validity standards

25/09/2009 | PSA tests for prostate cancer fail to meet the likelihood ratios formally required for a screening test, Swedish researchers have concluded.


More Genito-urinary Cancer news

Journals

Members of Oncology Update can access the following journals for free:

Most viewed articles this week

Recent comments

Related sites